4/A//SEC Filing
Celgene Alpine Investment Co., LLC 4/A
Accession 0001209191-18-006131
CIK 0001439222other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:39 AM ET
Size
11.0 KB
Accession
0001209191-18-006131
Insider Transaction Report
Form 4/AAmended
Celgene European Investment Co LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-01-23$67.00/sh+851,154$57,027,318→ 1,374,599 total
Holdings
- 5,343,834(indirect: See footnote)
Common Stock
CELGENE CORP /DE/
10% Owner
Transactions
- Purchase
Common Stock
2018-01-23$67.00/sh+851,154$57,027,318→ 1,374,599 total
Holdings
- 5,343,834(indirect: See footnote)
Common Stock
Celgene Switzerland LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-01-23$67.00/sh+851,154$57,027,318→ 1,374,599 total
Holdings
- 5,343,834(indirect: See footnote)
Common Stock
Celgene Alpine Investment Co., LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-01-23$67.00/sh+851,154$57,027,318→ 1,374,599 total
Holdings
- 5,343,834(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]This Form 4 Amendment is being submitted to correct the date of earliest transaction in box 3 to reflect January 23, 2018.
- [F2]Of these shares, 624,575 shares are owned directly by Celgene Switzerland LLC, 708,333 shares are owned directly by Celgene Alpine Investment Co. LLC, and 4,010,926 shares are owned directly by Celgene European Investment Company LLC, each a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Documents
Issuer
AGIOS PHARMACEUTICALS INC
CIK 0001439222
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001581774
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 8:39 AM ET
- Size
- 11.0 KB